Institutional Ownership Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM). We have compiled data on the 351 institutions that hold shares in the stock, with a total of 36.3 Million shares, which have been reported (via 13F filing form) to have a value of $4.69 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,051,365
shares
|
$558 Million
5.59% of portfolio
|
Q4 2024
Reduced 3.3%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,902,479
shares
|
$538 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.32%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,299,991
shares
|
$455 Million
0.01% of portfolio
|
Q2 2024
Added 3.27%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Feb 14, 2025 Q4 2024 |
1,468,983
shares
|
$202 Million
24.98% of portfolio
|
Q4 2024
Reduced 37.76%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,388,064
shares
|
$191 Million
4.4% of portfolio
|
Q4 2024
Added 32.7%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$138 Million
1.37% of portfolio
|
Q2 2024
New holding
|
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
964,047
shares
|
$133 Million
0.09% of portfolio
|
Q4 2024
Reduced 3.14%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
947,251
shares
|
$130 Million
0.0% of portfolio
|
Q4 2024
Added 3.32%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
912,538
shares
|
$126 Million
0.01% of portfolio
|
Q4 2024
Added 0.45%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
828,711
shares
|
$114 Million
1.34% of portfolio
|
Q4 2024
Added 0.1%
|
|
|
Alethea Capital Management, LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
734,317
shares
|
$101 Million
53.37% of portfolio
|
Q4 2024
Reduced 0.57%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
692,464
shares
|
$95.4 Million
0.01% of portfolio
|
Q4 2024
Added 10.76%
|
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
673,157
shares
|
$92.7 Million
0.01% of portfolio
|
Q4 2024
Reduced 9.37%
|
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
664,074
shares
|
$91.5 Million
1.87% of portfolio
|
Q4 2024
Reduced 15.17%
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Feb 14, 2025 Q4 2024 |
644,785
shares
|
$88.8 Million
0.94% of portfolio
|
Q4 2024
Added 3.15%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
576,858
shares
|
$79.5 Million
0.0% of portfolio
|
Q4 2024
Added 40.65%
|
|
|
Lazard Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
537,669
shares
|
$74.1 Million
0.07% of portfolio
|
Q4 2024
Added 525.69%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
495,389
shares
|
$68.2 Million
0.01% of portfolio
|
Q4 2024
Added 62.59%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
491,726
shares
|
$67.7 Million
3.39% of portfolio
|
Q4 2024
Added 29.56%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
467,427
shares
|
$64.4 Million
2.58% of portfolio
|
Q4 2023
Reduced 10.66%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
463,842
shares
|
$63.9 Million
0.04% of portfolio
|
Q2 2023
Added 13921.83%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
408,441
shares
|
$56.3 Million
0.26% of portfolio
|
Q4 2024
Added 36.8%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
403,026
shares
|
$55.5 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
402,500
shares
|
$55.4 Million
0.0% of portfolio
|
Q4 2024
Added 21.02%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
328,034
shares
|
$45.2 Million
0.01% of portfolio
|
Q4 2024
Added 1.69%
|